Can my GP prescribe a GLP-1 for weight loss in Scotland?

Sometimes—but an NHS GP in Scotland will not usually be able to start a GLP-1 weight-loss medicine simply because a patient asks for one. NHS access depends on the medicine’s licence, national recommendations, local NHS board arrangements and whether the person meets the relevant clinical criteria. In many cases, assessment and prescribing are routed through a specialist weight-management service rather than routine general practice.

A GLP-1 receptor agonist is a medicine that acts on receptors involved in appetite, digestion and blood-sugar regulation. Semaglutide is one example; tirzepatide acts on related hormone pathways as well. These medicines can support weight loss for some people, but they are not suitable for everyone and require clinical assessment and follow-up.

This guide explains the difference between NHS and private routes, what to ask your GP, how the specialist review process may work, and what to know about oral GLP-1 medicines. Local pathways can change, so check current information from your NHS board before making decisions.

How GLP-1 medicines affect appetite and fullness

GLP-1 is a hormone released after eating that helps regulate blood glucose and appetite. Medicines that mimic its action can increase feelings of fullness, affect how quickly the stomach empties, and reduce appetite. The precise effects and experience vary between individuals.

For some people, treatment also reduces persistent thoughts about food, sometimes called food noise. That phrase is not a medical diagnosis; it describes the distracting or repetitive mental effort some people experience around eating. Weight is influenced by many factors—including biology, health conditions, medicines, sleep, stress, income and food access—so it is not simply a matter of willpower.

GLP-1 medicines are one part of care, not a replacement for individual support. They can cause side effects, commonly digestive symptoms such as nausea, diarrhoea or constipation, and a clinician should discuss risks, expected benefits and how treatment will be monitored. They are generally intended to be used alongside support for nutrition, activity and other health needs, not as a quick fix.

Can an NHS GP prescribe one in Scotland?

A GP can assess your health, discuss weight-management options and refer you to an appropriate service. Whether they can prescribe a particular medicine through the NHS depends on the medicine and the local pathway. NHS funding does not follow automatically from a drug being Wegovy UK private prescription licensed: Scottish Medicines Consortium (SMC) advice and local NHS arrangements help determine whether, and for whom, a medicine is available.

For weight management, NHS prescribing may be restricted to people who meet specific criteria and receive care through a designated service. In practice, that can mean a GP makes a referral, while a specialist team assesses suitability and manages treatment. Some GPs may prescribe under an agreed local arrangement, but this should not be assumed across Scotland.

GP prescribing pathways therefore vary. A GP may be able to initiate treatment in one situation but not another, or may be asked to refer rather than prescribe directly. The answer can also depend on whether the medicine is being considered for weight management or for a separate licensed indication, such as type 2 diabetes.

What about NHS Grampian guidance?

If you live in NHS Grampian, ask your GP or local weight-management service what the current pathway is for your circumstances. NHS Grampian guidance and service arrangements can change, and eligibility may depend on local capacity as well as national recommendations. Do not rely on an old webpage, social-media post or another person’s experience as proof that the same route is available to you.

When you contact your GP, you could ask:

• Is there a local NHS weight-management service I can be referred to?
• Which medicines, if any, are currently available through the NHS pathway?
• What eligibility criteria apply, and what assessment or support is required?
• How long might referral and review take, and who should I contact if my health changes while waiting?

Your GP can also check whether other health conditions or medicines affect your options. If your weight is affecting your health, it is reasonable to ask for support without needing to justify yourself or meet a particular personal goal.

What happens during the specialist review process?

A specialist review is an assessment by an appropriately trained clinician or team to decide whether a treatment is suitable and how to provide it safely. The exact process differs by service, but it may include a discussion of your health history, previous support, current medicines, relevant measurements and treatment preferences.

The team should explain the likely benefits and limitations, possible side effects, follow-up arrangements and what happens if the medicine is not suitable or does not work well for you. They may also consider other causes of weight change or conditions that need separate assessment. A referral does not guarantee a prescription.

Ask how often you will be reviewed, how to report side effects, and what support is available if treatment needs to stop. Do not change or stop prescribed medicines without speaking to the prescriber, particularly if you take treatment for diabetes or another long-term condition.

MHRA approval is not the same as NHS availability

The MHRA is the UK regulator responsible for assessing medicines’ quality, safety and effectiveness and for authorising them for particular uses. A medicine’s licence sets out the conditions under which it may be used; it does not mean every patient is eligible or that the NHS will fund it.

For NHS use in Scotland, the regulatory decision is only one part of the picture. SMC advice, local NHS board decisions, service capacity and clinical criteria also matter. This is why a medicine may be authorised for weight management but still be available only through a restricted pathway, or not routinely offered in a particular area.

Question What it means Is it MHRA-authorised? Is the medicine licensed in the UK for this use, and under what conditions? Is it recommended or funded in Scotland? What do Scottish medicines advice and local NHS arrangements say about access? Am I eligible? Do I meet the clinical and service criteria, and is treatment appropriate for me?

Can I get a GLP-1 privately from a pharmacy?

Some regulated private providers offer weight-management assessments and may prescribe a medicine when it is clinically appropriate. A private pharmacy clinical assessment should involve a real review by a qualified prescriber—not just an online questionnaire that automatically leads to a sale.

Before paying, check that the pharmacy is registered with the General Pharmaceutical Council (GPhC), and establish who will assess you, prescribe, dispense and provide follow-up. The prescriber should ask about your medical history, current medicines and relevant risks, explain the options and tell you what to do if you develop side effects. You should be able to ask questions before deciding.

Private prescribing is separate from NHS care. You normally pay for the consultation, medicine and any ongoing reviews, and the cost can continue for as long as treatment is used. A private prescription does not guarantee that your GP or NHS service will take over prescribing later. Tell your GP about private treatment so your care and medicines record can be kept accurate, and do not use more than one provider for the same treatment without coordination.

Avoid sellers offering prescription-only medicines without a proper assessment, unusually low prices, or claims of guaranteed results. Medicines bought from unregulated websites may be counterfeit, incorrectly stored or otherwise unsafe. If you are uncertain, check the provider’s registration and discuss the offer with a healthcare professional.

Are oral GLP-1 medicines an option?

Oral treatment can sound more convenient than an injection, but the route of administration does not establish that a medicine is licensed or available for weight loss. In the UK, oral semaglutide has been used for type 2 diabetes; that does not automatically make it an approved or NHS-funded weight-loss treatment. Licensing and availability can change, so check the current MHRA product information and ask a prescriber about the specific medicine and indication.

Do not use tablets prescribed for diabetes as a workaround for access to weight-management treatment, and do not buy them without a prescription. Oral medicines may have specific instructions about when and how to take them, and a clinician should assess whether they are appropriate. Convenience matters, but so do evidence, safety, cost and follow-up.

How to prepare for a GP appointment

You do not need to arrive with a preferred drug name or a complete treatment plan. It may help to describe how your weight affects your health and daily life, what support you have tried or would welcome, and any concerns about medicines or eating. You can also ask for an interpreter, accessible information or a longer appointment if needed.

1. Ask about the local route. Find out whether your GP can assess or refer you, and which service manages weight-management medicines.
2. Check the criteria. Ask what information the service needs and whether there are other treatments or supports to consider.
3. Discuss safety. Tell the clinician about all medicines, supplements, health conditions and any previous side effects from treatment.
4. Agree a follow-up plan. Clarify who will monitor treatment, how to raise concerns and what happens if the medicine is unsuitable.

The bottom line

Your GP in Scotland can help you explore GLP-1 treatment, but may not be able to prescribe it directly for weight loss. Access depends on the medicine’s authorisation, Scottish and local NHS decisions, your clinical circumstances and the service responsible for care. In NHS Grampian, confirm the current pathway with your GP or local service rather than assuming that rules elsewhere apply.

If you consider private treatment, make sure a regulated provider carries out a thorough clinical assessment and offers follow-up. Whether treatment is NHS or private, a GLP-1 medicine should be part of a safe, monitored plan—not a judgement about your effort or character.